Condition: Glycogen Storage Disease Type I · Sponsor: Insel Gruppe AG, University Hospital Bern
The present project will specifically assess metabolic effects of dietary interventions with controlled intake of fructose and fructose/galactose in GSDI, with the aim to provide evidence whether relaxed dietary restrictions of fructose and galactose may be justified in treatment recommendations at least for adults, which would considerably enlarge food choice in everyday life of the patients with an expected positive impact on the quality of life of patients with this rare disorder.
This description comes directly from the study's public registry record.
Michel Hochuli, MD, PhD · +41 31 664 03 18 · michel.hochuli@insel.ch
Always discuss trial participation with your own doctor first.
| Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital | Bern, Switzerland | Recruiting |
| Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich | Zurich, Switzerland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06852612